BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2444252)

  • 1. Characterization of recombinant human alpha 2-antiplasmin and of mutants obtained by site-directed mutagenesis of the reactive site.
    Holmes WE; Lijnen HR; Collen D
    Biochemistry; 1987 Aug; 26(16):5133-40. PubMed ID: 2444252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of alpha 2-antiplasmin by limited reaction with cis-dichlorodiammineplatinum (II).
    Geary WA; Gonias SL
    Biochim Biophys Acta; 1989 Jan; 994(1):1-6. PubMed ID: 2521201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reactive site of human alpha 2-antiplasmin.
    Shieh BH; Travis J
    J Biol Chem; 1987 May; 262(13):6055-9. PubMed ID: 2437112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-2-antiplasmin: a serpin with two separate but overlapping reactive sites.
    Potempa J; Shieh BH; Travis J
    Science; 1988 Aug; 241(4866):699-700. PubMed ID: 2456616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosslinking of alpha 2-antiplasmin to fibrin.
    Lee KN; Lee CS; Tae WC; Jackson KW; Christiansen VJ; McKee PA
    Ann N Y Acad Sci; 2001; 936():335-9. PubMed ID: 11460490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bovine alpha 2-antiplasmin. N-terminal and reactive site sequence.
    Christensen S; Sottrup-Jensen L
    FEBS Lett; 1992 Nov; 312(1):100-4. PubMed ID: 1385210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary structure of bovine alpha 2-antiplasmin.
    Christensen S; Berglund L; Sottrup-Jensen L
    FEBS Lett; 1994 May; 343(3):223-8. PubMed ID: 7513654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
    Edelberg JM; Pizzo SV
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the antiplasmin activity of human thrombospondin-1 in solution.
    Anonick PK; Yoo JK; Webb DJ; Gonias SL
    Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):903-9. PubMed ID: 7679575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin).
    Holmes WE; Nelles L; Lijnen HR; Collen D
    J Biol Chem; 1987 Feb; 262(4):1659-64. PubMed ID: 2433286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of amino acids in antiplasmin involved in its noncovalent 'lysine-binding-site'-dependent interaction with plasmin.
    Wang H; Yu A; Wiman B; Pap S
    Eur J Biochem; 2003 May; 270(9):2023-9. PubMed ID: 12709062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human alpha 2-plasmin inhibitor.
    Aoki N; Sumi Y; Miura O; Hirosawa S
    Methods Enzymol; 1993; 223():185-97. PubMed ID: 8271952
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical significance of alpha 1-antitrypsin-elastase (alpha 1AT-ELP) and alpha 2-antiplasmin-plasmin (alpha 2AP-PL) complexes for the differentiation of coagulation protein turnover: indications for plasma protein substitution in patients with septicaemia.
    Seitz R; Egbring R; Radtke KP; Wolf M; Fuchs G; Fischer J; Lerch L; Karges HE
    Int J Tissue React; 1985; 7(4):321-8. PubMed ID: 2933357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha 2-antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activity.
    Holmes WE; Lijnen HR; Nelles L; Kluft C; Nieuwenhuis HK; Rijken DC; Collen D
    Science; 1987 Oct; 238(4824):209-11. PubMed ID: 2958938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural/functional characterization of the alpha 2-plasmin inhibitor C-terminal peptide.
    Frank PS; Douglas JT; Locher M; LlinĂ¡s M; Schaller J
    Biochemistry; 2003 Feb; 42(4):1078-85. PubMed ID: 12549929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of wild-type and mutant alpha2-antiplasmins: fibrinolysis enhancement by reactive site mutant.
    Lee KN; Tae WC; Jackson KW; Kwon SH; McKee PA
    Blood; 1999 Jul; 94(1):164-71. PubMed ID: 10381509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the plasminogen-binding site of human alpha 2-plasmin inhibitor.
    Sasaki T; Morita T; Iwanaga S
    J Biochem; 1986 Jun; 99(6):1699-705. PubMed ID: 3745142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.
    Anonick PK; Gonias SL
    Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):53-9. PubMed ID: 1708234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of portal region lysine residues in electrostatic interactions between heart fatty acid binding protein and phospholipid membranes.
    Herr FM; Aronson J; Storch J
    Biochemistry; 1996 Jan; 35(4):1296-303. PubMed ID: 8573586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reaction of human alpha2-antiplasmin and plasmin stopped-flow fluorescence kinetics.
    Christensen U; Bangert K; Thorsen S
    FEBS Lett; 1996 May; 387(1):58-62. PubMed ID: 8654567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.